Literature DB >> 15555878

Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital.

Ursula Changela1, Joan P Cannon, Chinyere Aneziokoro, Palak S Shah, Lizy Thottapurathu, Joseph Lentino.   

Abstract

The objective of this study was to evaluate the risk of certain patient co-morbidities and antibiotics in the development of Clostridium difficile-associated diarrhoea (CDAD). Hospitalized patients developing CDAD during a specified period were compared with a cohort of patients, matched by age, without a diagnosis of CDAD, who were hospitalized during the same time period. Data collection included demographics, hospital ward, co-morbid conditions, antibiotics received, and mortality. Gender and age were similar in both groups. Co-morbid conditions significantly associated with the case group included cancer and COPD. The most commonly prescribed antibiotics in the case versus control group included levofloxacin, intravenous vancomycin, clindamycin, and piperacillin/tazobactam. The case group was associated with a higher mortality rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15555878     DOI: 10.1016/j.ijantimicag.2004.07.011

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Predictors of Clostridium difficile colitis infections in hospitals.

Authors:  R Ricciardi; K Harriman; N N Baxter; L K Hartman; R J Town; B A Virnig
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

2.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

3.  Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection?

Authors:  R Ricciardi; J Nelson; J L Griffith; T W Concannon
Journal:  J Hosp Infect       Date:  2011-12-01       Impact factor: 3.926

4.  Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.

Authors:  Brian T Bateman; Jeremy A Rassen; Sebastian Schneeweiss; Katsiaryna Bykov; Jessica Myers Franklin; Joshua J Gagne; Jennifer M Polinski; Jun Liu; Alexander Kulik; Michael A Fischer; Niteesh K Choudhry
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-28       Impact factor: 5.209

Review 5.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

Authors:  Archie C A Clements; Ricardo J Soares Magalhães; Andrew J Tatem; David L Paterson; Thomas V Riley
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

Review 6.  Mortality in hospitalized older adults associated with Clostridium difficile infection at a district hospital.

Authors:  Johannis Andreas Karas; Simon Bradshaw; Wabbas Mahmud; David A Enoch
Journal:  Infect Dis Rep       Date:  2010-06-21

7.  The simple predictors of pseudomembranous colitis in patients with hospital-acquired diarrhea: a prospective observational study.

Authors:  Bo Kyung Yang; Byung Ju Do; Eun Jung Kim; Ji Un Lee; Mi Hee Kim; Jin Gu Kang; Hyoung Su Kim; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Hak Yang Kim; Woon Geon Shin
Journal:  Gut Liver       Date:  2013-11-05       Impact factor: 4.519

8.  Analysis of risk factors and clinical manifestations associated with Clostridium difficile disease in Serbian hospitalized patients.

Authors:  Stojanović Predrag
Journal:  Braz J Microbiol       Date:  2016-07-25       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.